Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis

Abstract Toxoplasmosis, a common parasitic disease, is caused by Toxoplasma gondii, which infects approximately 30% of the world’s population. This obligate intracellular protozoan causes significant economic losses and poses serious public health challenges worldwide. However, the development of an...

Full description

Bibliographic Details
Main Authors: Minmin Wu, Shutong Liu, Ying Chen, Deng Liu, Ran An, Haijian Cai, Jie Wang, Nan Zhou, Cudjoe Obed, Meng Han, Jilong Shen, Lijian Chen, Jian Du
Format: Article
Language:English
Published: Nature Portfolio 2022-08-01
Series:npj Vaccines
Online Access:https://doi.org/10.1038/s41541-022-00518-5
_version_ 1797642432343441408
author Minmin Wu
Shutong Liu
Ying Chen
Deng Liu
Ran An
Haijian Cai
Jie Wang
Nan Zhou
Cudjoe Obed
Meng Han
Jilong Shen
Lijian Chen
Jian Du
author_facet Minmin Wu
Shutong Liu
Ying Chen
Deng Liu
Ran An
Haijian Cai
Jie Wang
Nan Zhou
Cudjoe Obed
Meng Han
Jilong Shen
Lijian Chen
Jian Du
author_sort Minmin Wu
collection DOAJ
description Abstract Toxoplasmosis, a common parasitic disease, is caused by Toxoplasma gondii, which infects approximately 30% of the world’s population. This obligate intracellular protozoan causes significant economic losses and poses serious public health challenges worldwide. However, the development of an effective toxoplasmosis vaccine in humans remains a challenge to date. In this study, we observed that the knockout of calcium-dependent protein kinase 3 (CDPK3) in the type II ME49 strain greatly attenuated virulence in mice and significantly reduced cyst formation. Hence, we evaluated the protective immunity of ME49Δcdpk3 as a live attenuated vaccine against toxoplasmosis. Our results showed that ME49Δcdpk3 vaccination triggered a strong immune response marked by significantly elevated proinflammatory cytokine levels, such as IFN-γ, IL-12, and TNF-α, and increased the percentage of CD4+ and CD8+ T-lymphocytes. The high level of Toxoplasma-specific IgG was maintained, with mixed IgG1/IgG2a levels. Mice vaccinated with ME49Δcdpk3 were efficiently protected against the tachyzoites of a variety of wild-type strains, including type I RH, type II ME49, Chinese 1 WH3 and Chinese 1 WH6, as well as the cysts of wild-type strains ME49 and WH6. These data demonstrated that ME49Δcdpk3 inoculation induced effective cellular and humoral immune responses against acute and chronic Toxoplasma infections with various strains and was a potential candidate to develop a vaccine against toxoplasmosis.
first_indexed 2024-03-11T14:01:10Z
format Article
id doaj.art-57df80eb3d0f449f9872b461e46a7b45
institution Directory Open Access Journal
issn 2059-0105
language English
last_indexed 2024-03-11T14:01:10Z
publishDate 2022-08-01
publisher Nature Portfolio
record_format Article
series npj Vaccines
spelling doaj.art-57df80eb3d0f449f9872b461e46a7b452023-11-02T04:39:22ZengNature Portfolionpj Vaccines2059-01052022-08-017111010.1038/s41541-022-00518-5Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosisMinmin Wu0Shutong Liu1Ying Chen2Deng Liu3Ran An4Haijian Cai5Jie Wang6Nan Zhou7Cudjoe Obed8Meng Han9Jilong Shen10Lijian Chen11Jian Du12Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical UniversityThe Research Center for Infectious Diseases, School of Basic Medical Sciences, Anhui Medical UniversityDepartment of Anesthesiology, The First Affiliated Hospital of Anhui Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical UniversityThe Research Center for Infectious Diseases, School of Basic Medical Sciences, Anhui Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical UniversityThe Research Center for Infectious Diseases, School of Basic Medical Sciences, Anhui Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical UniversityThe Provincial Key Laboratory of Zoonoses of High Institutions of Anhui, Anhui Medical UniversityDepartment of Anesthesiology, The First Affiliated Hospital of Anhui Medical UniversityDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical UniversityAbstract Toxoplasmosis, a common parasitic disease, is caused by Toxoplasma gondii, which infects approximately 30% of the world’s population. This obligate intracellular protozoan causes significant economic losses and poses serious public health challenges worldwide. However, the development of an effective toxoplasmosis vaccine in humans remains a challenge to date. In this study, we observed that the knockout of calcium-dependent protein kinase 3 (CDPK3) in the type II ME49 strain greatly attenuated virulence in mice and significantly reduced cyst formation. Hence, we evaluated the protective immunity of ME49Δcdpk3 as a live attenuated vaccine against toxoplasmosis. Our results showed that ME49Δcdpk3 vaccination triggered a strong immune response marked by significantly elevated proinflammatory cytokine levels, such as IFN-γ, IL-12, and TNF-α, and increased the percentage of CD4+ and CD8+ T-lymphocytes. The high level of Toxoplasma-specific IgG was maintained, with mixed IgG1/IgG2a levels. Mice vaccinated with ME49Δcdpk3 were efficiently protected against the tachyzoites of a variety of wild-type strains, including type I RH, type II ME49, Chinese 1 WH3 and Chinese 1 WH6, as well as the cysts of wild-type strains ME49 and WH6. These data demonstrated that ME49Δcdpk3 inoculation induced effective cellular and humoral immune responses against acute and chronic Toxoplasma infections with various strains and was a potential candidate to develop a vaccine against toxoplasmosis.https://doi.org/10.1038/s41541-022-00518-5
spellingShingle Minmin Wu
Shutong Liu
Ying Chen
Deng Liu
Ran An
Haijian Cai
Jie Wang
Nan Zhou
Cudjoe Obed
Meng Han
Jilong Shen
Lijian Chen
Jian Du
Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis
npj Vaccines
title Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis
title_full Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis
title_fullStr Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis
title_full_unstemmed Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis
title_short Live-attenuated ME49Δcdpk3 strain of Toxoplasma gondii protects against acute and chronic toxoplasmosis
title_sort live attenuated me49δcdpk3 strain of toxoplasma gondii protects against acute and chronic toxoplasmosis
url https://doi.org/10.1038/s41541-022-00518-5
work_keys_str_mv AT minminwu liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT shutongliu liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT yingchen liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT dengliu liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT ranan liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT haijiancai liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT jiewang liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT nanzhou liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT cudjoeobed liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT menghan liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT jilongshen liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT lijianchen liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis
AT jiandu liveattenuatedme49dcdpk3strainoftoxoplasmagondiiprotectsagainstacuteandchronictoxoplasmosis